News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By John Vidal, The Guardian | 01.04.2013
Britain wants GM food to be grown commercially. After years of encouraging developing countries in Africa and elsewhere to grow...
By Patrick Lin, The Atlantic | 01.04.2013
Science fiction, or actual U.S. military project? Half a world away from the battlefield, a soldier controls his avatar-robot that...
By Mira Kamdar, The Atlantic | 01.04.2013
My first sense as a young girl of sexual menace came from my Indian grandfather. He never sexually threatened or...
By Ben Hirschler, Reuters | 01.03.2013
The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease...
By Yun Suh-young, The Korea Times | 01.03.2013
Stem cell research company RNL Bio faced allegations Thursday that it “smuggled” stem cells and related equipment overseas.

According to...
By Susan Berfield, Bloomberg Businessweek | 01.03.2013
Cecelia Johnson was an artist, cellist, tap dancer, and 22-year-old college student when she was diagnosed with multiple sclerosis in...
By Kyoko Hasegawa, inSing | 01.03.2013
(TOKYO) Hideaki Kato discovered his true identity by accident.

During his medical training a decade ago, the now 39-year-old Japanese...
By Marcia Heroux Pounds, Sun Sentinel | 01.03.2013
Boca Raton parents Gary and Judy Susser say the know the hope and promise of stem-cell therapy. Nine years ago...